COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Background: To determine the effect of disease-modifying therapies (DMT) on humoral postvaccine seroconversion, long-term humoral response, and breakthrough COVID-19 infections in persons with multiple sclerosis (PwMS) and other neuroinflammatory disorders. Methods: A total of 757 PwMS and other neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakimovski, Dejan, Zakalik, Karen, Awan, Samreen, Kavak, Katelyn S., Pennington, Penny, Hojnacki, David, Kolb, Channa, Lizarraga, Alexis A., Eckert, Svetlana P., Sarrosa, Rosila, Vineetha, Kamath, Edwards, Keith, Weinstock-Guttman, Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146267/
https://www.ncbi.nlm.nih.gov/pubmed/35632451
http://dx.doi.org/10.3390/vaccines10050695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146267/
https://www.ncbi.nlm.nih.gov/pubmed/35632451
http://dx.doi.org/10.3390/vaccines10050695

Ejemplares similares